Placenta Accreta Clinical Trial
Official title:
Topical Adrenaline Versus Warm Saline Solution for Minimizing Intraperitoneal Bleeding During Caesarian Delivery for Placenta Previa / Accreta Spectrum ( PAS): A Randomized Controlled Study
Placenta accreta spectrum (PAS), encompassing the terms placenta accreta, increta, and percreta; abnormally invasive placenta; morbidly adherent placenta; and invasive placentation, is a leading cause of life-threatening obstetric haemorrage . Currently, more than 90% of women diagnosed with PAS also have a placenta praevia , and the combination of both conditions leads to high maternal morbidity and mortality due to massive haemorrhage at the time of birth . Maternal mortality of placenta praevia with percreta has been reported to be as high as 7% of cases . Adrenaline has also been demonstrated to be a reasonable hemostatic agent because of its low cost, low risk, powerful vasoconstrictor, and platelet aggregation. Topical use of adrenaline is an effective and reasonable hemostatic agent in tonsillectomy.
- Population of study: A total of 84 pregnant patients with placenta previa / Accreta spectrum. - Study location: Obstetrics and Gynecology Kasr Al-Ainy Hospital , Faculty of Medicine , Cairo University. This is a randomized controlled trial including a total number of 84 patients representing study group , randomized in 2 equal groups , using computer generated randomization sheet on (Medcalc ®) . Group A : Topical adrenaline group (n=42) Group B : Warm saline Group (control) (n=42) The aim of the study is to evaluate the efficacy of topical adrenaline for decreasing intraperitoneal bleeding during caesarian section for placenta previa/ Accreta spectrum (PAS). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04579172 -
Conservative Management of Morbidly Adherent Anterior Situated Placenta
|
N/A | |
| Completed |
NCT04593303 -
Internal Iliac Artery Ligation During Management of Placenta Accreta Spectrum
|
N/A | |
| Recruiting |
NCT03638024 -
Cell-free Fetal DNA Concentration in Cases of Abnormal Placental Invasion .
|
||
| Not yet recruiting |
NCT06100640 -
Paracervical Pouch in Placenta Accreta Spectrum
|
||
| Completed |
NCT05979181 -
Peripartum Cesarean Hysterectomy for Placenta Percreta
|
||
| Recruiting |
NCT04609527 -
Management of Placenta Accreta Spectrum
|
Phase 2/Phase 3 | |
| Recruiting |
NCT06185894 -
The Role of Using Tourniquet in Decreasing Bleeding in Placenta Accreta Spectrum Cases
|
N/A | |
| Completed |
NCT04573452 -
Galectin-3 and Placenta Accreta
|
||
| Not yet recruiting |
NCT03273569 -
PDIUC Protocol for Placental Accreta
|
N/A | |
| Completed |
NCT03707132 -
Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
|
||
| Not yet recruiting |
NCT05104177 -
Effectivness of Conservative Techniques in Management of PAS
|
||
| Completed |
NCT02806024 -
Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study
|
Phase 4 | |
| Active, not recruiting |
NCT02784886 -
Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta
|
N/A | |
| Recruiting |
NCT05070689 -
Placenta Accreta Spectrum Disorders: A. Chohan Continuous Squeezing Suture (ACCSS)
|
N/A | |
| Completed |
NCT05813743 -
Detection of Urinary Bladder Wall Involvement in Abnormally Invasive Placenta (AIP) by 3D Ultrasonography
|
N/A | |
| Withdrawn |
NCT04003428 -
Feasibility of HIFU for Management of Placenta Accreta (HIFU-ACCRETA)
|
N/A | |
| Completed |
NCT04161521 -
Conservative Surgical Novel Technique of Placenta Accreta in Menoufia University Hospital
|
N/A | |
| Recruiting |
NCT05139498 -
Conservative Management for PAS Pilot
|
N/A | |
| Not yet recruiting |
NCT03530475 -
Diagnostic Accuracy of Doppler Ultrasound and Role of Uterine Artery Doppler
|
N/A | |
| Recruiting |
NCT05922397 -
Placenta Accreta Spectrum Topographic Classification
|